| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
Form 4: Roberts Eiry, Chief Medical Officer
Granted 8,314 Stock Option · Granted 1,506 Restricted Stock Unit |
| 03 Nov 2026 |
Form 4: Morrow George J, Director
Received 300 shares by exercise or conversion ($16.1K) · Sold 300 shares ($44.7K) · Received 7,500 shares by exercise or conversion ($402K) · 3 more |
| 03 Nov 2026 |
Form 4: Gano Kyle, Director
Received 614 shares by exercise or conversion · Gave up 332 shares to cover exercise price or tax ($48.5K) |
| 15 Sep 2026 |
Form 4: Onyia Jude, Chief Scientific Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) |
| 15 Sep 2026 |
Form 4: Lippoldt Darin, Chief Legal Officer
Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K) |
| 15 Sep 2026 |
Form 4: Keswani Sanjay Chandru, Chief Medical Officer
Received 3,914 shares as a grant or award · Gave up 2,112 shares to cover exercise price or tax ($330K) |
| 15 Sep 2026 |
Form 4: Gorman Kevin Charles, Director
Received 14,343 shares as a grant or award · Gave up 7,839 shares to cover exercise price or tax ($1.22M) |
| 15 Sep 2026 |
Form 4: Gano Kyle, Director
Received 8,117 shares as a grant or award · Gave up 4,380 shares to cover exercise price or tax ($684K) |
| 15 Sep 2026 |
Form 4: Delaet Ingrid, Chief Regulatory Officer
Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K) |
| 15 Sep 2026 |
Form 4: Cooke Julie, Chief Human Resources Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) |
| 15 Sep 2026 |
Form 4: Boyer David W., Chief Corp. Affairs Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) · Sold 826 shares ($130K) |
| 15 Sep 2026 |
Form 4: Benevich Eric, Chief Commercial Officer
Received 6,275 shares as a grant or award · Gave up 3,386 shares to cover exercise price or tax ($529K) |
| 15 Sep 2026 |
Form 4: Abernethy Matt, Chief Financial Officer
Received 5,020 shares as a grant or award · Gave up 2,709 shares to cover exercise price or tax ($423K) · Sold 2,311 shares ($363K) |
| 10 Sep 2026 |
Form 4: Benevich Eric, Chief Commercial Officer
Received 3,194 shares by exercise or conversion ($138K) · Sold 2,154 shares ($333K) |
| 03 Sep 2026 |
Form 4: Sherwin Stephen A, Director
Gave 1,000 shares as a gift |
| 05 Aug 2026 |
Form 4: Onyia Jude, Chief Scientific Officer
Gave 2,409 shares as a gift |
| 30 Jul 2026 |
Form 4: Norwalk Leslie V, Director
Sold 1,250 shares ($228K) · Received 842 shares by exercise or conversion ($117K) |
| 13 Jul 2026 |
Form 4: Delaet Ingrid, Chief Regulatory Officer
Received 4,367 shares by exercise or conversion ($463K) · Sold 4,367 shares ($791K) |
| 13 Jul 2026 |
Form 4: Lippoldt Darin, Chief Legal Officer
Received 10,000 shares by exercise or conversion ($815K) · Sold 10,000 shares ($1.8M) |
| 09 Jul 2026 |
Form 4: Delaet Ingrid, Chief Regulatory Officer
Received 3,401 shares by exercise or conversion ($352K) · Sold 3,401 shares ($607K) · Received 2,737 shares by exercise or conversion ($283K) · 3 more |
Loading...